Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.
Sanchez-Niño MD, Bozic M, Córdoba-Lanús E, Valcheva P, Gracia O, Ibarz M, Fernandez E, Navarro-Gonzalez JF, Ortiz A, Valdivielso JM. Sanchez-Niño MD, et al. Among authors: valdivielso jm. Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F647-57. doi: 10.1152/ajprenal.00090.2011. Epub 2011 Dec 14. Am J Physiol Renal Physiol. 2012. PMID: 22169009 Free article.
Inflammation in Diabetic Kidney Disease.
Pérez-Morales RE, Del Pino MD, Valdivielso JM, Ortiz A, Mora-Fernández C, Navarro-González JF. Pérez-Morales RE, et al. Among authors: valdivielso jm. Nephron. 2019;143(1):12-16. doi: 10.1159/000493278. Epub 2018 Oct 1. Nephron. 2019. PMID: 30273931 Review.
Lipid management in patients with chronic kidney disease.
Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C. Ferro CJ, et al. Among authors: valdivielso jm. Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Nat Rev Nephrol. 2018. PMID: 30361677 Free article. Review.
Author Correction: Lipid management in patients with chronic kidney disease.
Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C. Ferro CJ, et al. Among authors: valdivielso jm. Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y. Nat Rev Nephrol. 2019. PMID: 30538326
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M. Sarafidis P, et al. Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230. doi: 10.1093/ndt/gfy407. Nephrol Dial Transplant. 2019. PMID: 30753708
188 results